Cargando…
Is it oncologically and clinically safe to adopt a bladder sparing approach in complete responders following neoadjuvant chemotherapy alone without proceeding to a radical cystectomy?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323285/ https://www.ncbi.nlm.nih.gov/pubmed/30687613 http://dx.doi.org/10.21037/tau.2018.08.18 |
| _version_ | 1783385732309581824 |
|---|---|
| author | Arianayagam, Ranjan Sharma, Anand Vasdev, Nikhil |
| author_facet | Arianayagam, Ranjan Sharma, Anand Vasdev, Nikhil |
| author_sort | Arianayagam, Ranjan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6323285 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-63232852019-01-25 Is it oncologically and clinically safe to adopt a bladder sparing approach in complete responders following neoadjuvant chemotherapy alone without proceeding to a radical cystectomy? Arianayagam, Ranjan Sharma, Anand Vasdev, Nikhil Transl Androl Urol Editorial AME Publishing Company 2018-12 /pmc/articles/PMC6323285/ /pubmed/30687613 http://dx.doi.org/10.21037/tau.2018.08.18 Text en 2018 Translational Andrology and Urology. All rights reserved. |
| spellingShingle | Editorial Arianayagam, Ranjan Sharma, Anand Vasdev, Nikhil Is it oncologically and clinically safe to adopt a bladder sparing approach in complete responders following neoadjuvant chemotherapy alone without proceeding to a radical cystectomy? |
| title | Is it oncologically and clinically safe to adopt a bladder sparing approach in complete responders following neoadjuvant chemotherapy alone without proceeding to a radical cystectomy? |
| title_full | Is it oncologically and clinically safe to adopt a bladder sparing approach in complete responders following neoadjuvant chemotherapy alone without proceeding to a radical cystectomy? |
| title_fullStr | Is it oncologically and clinically safe to adopt a bladder sparing approach in complete responders following neoadjuvant chemotherapy alone without proceeding to a radical cystectomy? |
| title_full_unstemmed | Is it oncologically and clinically safe to adopt a bladder sparing approach in complete responders following neoadjuvant chemotherapy alone without proceeding to a radical cystectomy? |
| title_short | Is it oncologically and clinically safe to adopt a bladder sparing approach in complete responders following neoadjuvant chemotherapy alone without proceeding to a radical cystectomy? |
| title_sort | is it oncologically and clinically safe to adopt a bladder sparing approach in complete responders following neoadjuvant chemotherapy alone without proceeding to a radical cystectomy? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323285/ https://www.ncbi.nlm.nih.gov/pubmed/30687613 http://dx.doi.org/10.21037/tau.2018.08.18 |
| work_keys_str_mv | AT arianayagamranjan isitoncologicallyandclinicallysafetoadoptabladdersparingapproachincompleterespondersfollowingneoadjuvantchemotherapyalonewithoutproceedingtoaradicalcystectomy AT sharmaanand isitoncologicallyandclinicallysafetoadoptabladdersparingapproachincompleterespondersfollowingneoadjuvantchemotherapyalonewithoutproceedingtoaradicalcystectomy AT vasdevnikhil isitoncologicallyandclinicallysafetoadoptabladdersparingapproachincompleterespondersfollowingneoadjuvantchemotherapyalonewithoutproceedingtoaradicalcystectomy |